Prevalence of depression and anxiety in children between 8-18years with beta thalassemia major: an observational study for a period of 1 year

Abstract

Background Beta Thalassemia Major (BTM) is a severe, chronic hematologic disorder characterized by a need for lifelong treatment, including regular blood transfusions and iron chelation therapy. Managing this chronic condition extends beyond physical health, presenting significant psychological and social challenges. The chronic nature of BTM and its demanding treatment regimen contribute to these elevated rates of mental health issues, impacting the quality of life and overall well-being of affected children. Identifying and managing psychological issues early is crucial for improving both immediate and long-term health outcomes for these children. Objectives The objectives of the study were to study the prevalence of depression and anxiety in children between 8-18years with beta thalassemia major, to study the quality of life in parents of children suffering from beta thalassemia and to study the sleep pattern of children suffering from beta thalassemia major